George Harrison Talbot, Director at Nabriva Therapeutics AG (NBRV), sold 170 shares at $93.50 ($16K) on 2017-06-16, disclosed to the SEC on 2017-06-19.
Open-market sale of $16k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.10 | 100 | $9K | 59.4% |
| 2 | $93.50 | 24 | $2K | 14.2% |
| 3 | $91.00 | 46 | $4K | 26.4% |
| Total | $93.18 avg | 170 | $16K | 100% |
| Filing → |
| NBRV | SELL | 2017-05-25 | $33K | — | Filing → |
| NBRV | SELL | 2017-05-17 | $21K | — | Filing → |